In addition, our experiments revealed that the suppressive impact of sh-ELAVL1 on the glycolytic ability of nasopharyngeal carcinoma cells was reversed upon subsequent overexpression of HMGB3. Here, ELAVL1 is linked to nasopharyngeal carcinoma.